US 10975094
Heterocyclic compounds as RSV inhibitors
granted A61PA61P31/16
Quick answer
US patent 10975094 (Heterocyclic compounds as RSV inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P31/16